Effect of omega-3 supplementation on serum lipids in patients on chronic hemodialysis

Bahman Bashardoost, Shahram Habibzadeh, Bita Shahbazzadegan, Saeid Sadeghieh Ahari, Elnaz Khodaei Ardabili, Amir Haddad


Background: Considering the important of effects resulting from chronic hemodialysis in patients having renal insufficiency of which cardio-vascular effect is the most important, this study has been done to examine the complementary effects of omega lipid on lipid profile serum and systemic inflammation index in these patients.

Methods: Patients in this study include two groups (intervention and control). They have been chosen from among the patient called on hemodialysis unit of Booali hospital. The interval group received one omega capsule daily and the control group received a placebo capsule one a day for three months. At the end, the results of lipid profile tests (including triglycerides (TG), low density lipoproteins (LDL) and high density lipoproteins (HDL)) and systemic inflammation index (C-reactive protein) compared before and after receiving the medicine.

Results: In this study in interval group having omega3 despite decrease in TG and increase in HDL after three months there were no meaningful changes. In group receiving placebo only increase of HDL was meaningful and despite decrease in TG after receiving placebo these changes was meaningless.

Conclusions: The results of this study showed that omega3 had no meaningful changes in lipidic profile of patients who were being hemodialysed.


Renal insufficiency, Hemodialysis, Omega-3, Lipid profile serum

Full Text:



Fiedler R, Mall M, Wand C, Osten B. Short-term administration of omega-3 fatty acids in hemodialysis patients with balanced lipid metabolism. J Ren Nutr. 2005;15:253-6.

Hassan KS, Hassan SK, Hijazi EG, Khazim KO. Effects of omega-3 on lipid profile and inflammation markers in peritoneal dialysis patients. Ren Fail. 2010;32:1031-5.

Rudkowska I, Garenc C, Couture P, Claude M. Omega-3 fatty acids regulate gene expression levels differently in subjects carrying the PPARα L162V polymorphism. Genes Nutr. 2009;4:199–205.

Ewers B, Riserus U, Marckmann P. Effects of unsaturated fat dietary supplements on blood lipids, and on markers of malnutrition and inflammation in hemodialysis patients. J Ren Nutr. 2009;19:401-11.

Friedman AN, Yu Z, Tabbey R, Denski C, Tamez H, Wenger J, et al. Low Blood Levels of Long-Chain n–3 Polyunsaturated Fatty Acids in US Hemodialysis Patients. Am J Nephrol. 2012;36:451-8.

Sarafrazi N, Atabak Sh, Valaee n, Kimiagar SM. study of comparative of vitamin E, omega-3 fatty acid and the combination of both fat and blood pressure in hemodialysis patients. Pajoohandeh J. 2001;6:9-15.

HU FB, Bronner L, Willett WC, Stampfer MJ, Rexrode KM, Albert CM, et al. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA. 2002;287:1815-21.

Madsen T, Schmidt EB, Christensen JH. The effect of n-3 fatty acids on C-reactive protein levels in patients with chronic renal failure. J Ren Nutr. 2007;17:258-63.

Perunicic-Pekovic GB, Rasic ZR, Pljesa SI, Sobajic SS, Djuricic I, Maletic R, et al. Effect of n-3 fatty acids on nutritional status and inflammatory markers in haemodialysis patients. Nephrology (Carlton). 2007;12:331-6.

Kutner NG, Clow PW, Zhang R, Aviles X. Association of fish intake and survival in a cohort of incident dialysis patients. Am J Kidney Dis. 2002;39:1018-24.

Colussi GL, Baroselli S, Sechi L. Omega-3 polyunsaturated fatty acids decrease plasma lipoprotein levels in hypertensive subjects. Clin Nutr. 2004;23:1246–7.

Woodman RJ, Mori TA, Burke V, Puddey IB, Barden A, Watts GF, et al. Effects of purified eicosapentaenoic acid and docosahexaenoic acid on platelet, fibrinolytic and vascular function in hypertensive type 2 diabetic patients. Atherosclerosis. 2003;166:85–93.

Longo DL, Anthonys M, Fauci AS, Dennis K, Stephen S, Hauser L, et al. Harrison’s principles of internal medicine 18th edition. Newyork McGraw Hill. 2012;3:2012-3148.

Shorecki K, Green J, Brenner BM, Braunwald E, Fauci AS, Hauser SL. Harrison’s Principles of internal Medicine16th edition. New York McGrawHill; 2005:1653-63.

Ziyadeh FN. Approach to the Patient with Chronic renal failure, Kelley’s Textbook of Internal Medicine. Philadelphia; 2000: 1133-34.

Bucher HC, Hengstler P, Schindler C, Meier G. N-3 polyunsaturated fatty acids in coronary heart disease:a meta-analysis of randomized controlled trials. Am J Med. 2002;112:298-304.

Leaf A, Kang JX, Xiao YF, Billman GE. Clinical prevention of arrhythmias by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation. 2003;107:2646-52.

Chan DC, Watts GF, Mori TA, Barrett PH, Redgrave TG, Beilin LJ. Randomized controlled trial of the effect of n-3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity. Am J Clin Nutr. 2003;77:300-7.

Svensson M, Schmidt EB, Jørgensen KA, Christensen JH. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study. Nephrol Dial Transplant. 2008;23:2918–24.

Kooshki A, Taleban FA, Tabibi H, Norafshar R, Hedayati M. Effects of ω3-fatty Acid Supplement on Serum Lipids and Lipoproteins in Hemodialysis Patients. JSUMS. 2009;16:25-34.

Koshki A, Taleban F, Tabibi H, Hedayati M, Esmaeili M. Effects of dietary ω3-fatty acid supplementation on the serum systemic and vascular inflammation markers in hemodialysis patients. NSFT. 2009;4:1-11.

Rafraf M, Mohammadi E, Farzadi L, Asgharijafarabadi M. Effects of Omega-3 Fatty Acid Supplement on Serum Lipid Profile and Markers of Oxidative Stress in Women with Polycystic Ovary Syndrome. IJOGI 2012;15:1-10

U.S. Renal Data System, USRDS 2005 Annual Data Report. Atlas of End Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Kidney Diseases, Bethesda, MD; 2005.

Donnelly SM, Ali M, Churchill DN. Effect of n-3 fatty acids from fish oil on hemostasis, blood pressure, and lipid profile of dialysis patients. J Am Soc Nephrol. 1992;2:1634-9.